T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.47% |
| 2 | Healthcare | 18.68% |
| 3 | Consumer Discretionary | 13.32% |
| 4 | Financials | 12.13% |
| 5 | Communication Services | 10.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Quince Therapeutics
QNCX
$34.8M
| $3.8M | ﹤0.01% |
417
-69
| -14% | -$681K |
|
1377
Wolfspeed
WOLF
$1.61B
| $3.79M | ﹤0.01% |
106,822
+1,105
| +1% | +$49.6K |
|
|
Y
1378
DELISTED
Alleghany Corp
Y
| $3.79M | ﹤0.01% |
6,854
+826
| +14% | +$594K |
|
1379
Bio-Techne
TECH
$11.2B
| $3.76M | ﹤0.01% |
79,320
-3,324
| -4% | -$166K |
|
1380
Hawaiian Electric Industries
HE
$2.05B
| $3.76M | ﹤0.01% |
87,280
+715
| +0.8% | +$33.1K |
|
1381
Alarm.com
ALRM
$2.72B
| $3.75M | ﹤0.01% |
96,478
+72,860
| +308% | +$3.18M |
|
1382
Infosys
INFY
$49.3B
| $3.7M | ﹤0.01% |
450,831
+117,261
| +35% | +$1.18M |
|
|
CY
1383
DELISTED
Cypress Semiconductor
CY
| $3.63M | ﹤0.01% |
155,735
-27,036
| -15% | -$618K |
|
1384
Sabre
SABR
$884M
| $3.59M | ﹤0.01% |
606,154
-72,931
| -11% | -$1.22M |
|
|
DMTK
1385
DELISTED
DermTech, Inc. Common Stock
DMTK
| $3.56M | ﹤0.01% |
+333,333
| New | +$4.09M |
|
1386
Royal Bank of Canada
RY
$300B
| $3.55M | ﹤0.01% |
57,916
+3,436
| +6% | +$255K |
|
1387
Annaly Capital Management
NLY
$17.7B
| $3.55M | ﹤0.01% |
174,861
-29,830
| -15% | -$1.05M |
|
1388
Ciena
CIEN
$62.8B
| $3.53M | ﹤0.01% |
88,674
+12,308
| +16% | +$505K |
|
1389
Ingredion
INGR
$6.61B
| $3.53M | ﹤0.01% |
46,734
+2,480
| +6% | +$213K |
|
1390
Dell
DELL
$321B
| $3.46M | ﹤0.01% |
172,450
-67,909
| -28% | -$1.57M |
|
1391
Barings BDC
BBDC
$983M
| $3.43M | ﹤0.01% |
458,064
-1,373,519
| -75% | -$13M |
|
1392
Louisiana-Pacific
LPX
$5.16B
| $3.42M | ﹤0.01% |
198,825
+16,036
| +9% | +$444K |
|
1393
Under Armour
UAA
$2.29B
| $3.37M | ﹤0.01% |
365,997
+28,899
| +9% | +$464K |
|
1394
Coty
COTY
$2.44B
| $3.36M | ﹤0.01% |
650,511
+26,018
| +4% | +$244K |
|
1395
TETRA Technologies
TTI
$1.27B
| $3.34M | ﹤0.01% |
10,441,307
-438,432
| -4% | -$520K |
|
1396
Helmerich & Payne
HP
$4.43B
| $3.29M | ﹤0.01% |
210,176
+15,350
| +8% | +$541K |
|
1397
Toll Brothers
TOL
$13.9B
| $3.27M | ﹤0.01% |
170,026
-2,259
| -1% | -$85.5K |
|
|
AXON
1398
Axon Enterprise
AXON
$49.2B
| $3.27M | ﹤0.01% |
46,171
-56,651
| -55% | -$4.24M |
|
1399
Sonoco
SON
$5.73B
| $3.24M | ﹤0.01% |
69,806
+11,300
| +19% | +$602K |
|
1400
Capri Holdings
CPRI
$1.77B
| $3.22M | ﹤0.01% |
298,067
+20,613
| +7% | +$541K |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.